IMPORTANCE Most children with retinoblastoma in the United States are diagnosed as having a large intraocular tumor burden that requires intensive ocular-salvage treatment or enucleation.
R etinoblastoma is a rare childhood cancer; approximately 300 cases are diagnosed yearly in the United States and 9000 are diagnosed yearly worldwide. 1, 2 Retinoblastoma presents in a heritable, often bilateral, form that accounts for 25% of the cases and is characterized by the presence of a germline RB1 mutation (RefSeq NM_000321.2) and in a nonheritable unilateral form. 1 Treatment of retinoblastoma aims at cure, ocular salvage, and preservation of vision; thus, priorities must be established based on the laterality and the extent of disease. 1, 3 The presentation of retinoblastoma reflects the continuum of disease progression and the range of opportunities for diagnosis and ocular salvage. When diagnosed early, ocular salvage and preservation of vision are possible with relatively minimal therapy. [4] [5] [6] [7] The treatment of larger tumors is more complex; many patients require enucleation, and those with disease extension beyond the retina require chemotherapy and often orbital radiotherapy. 8 Patients with advanced intraocular disease who are candidates for ocular salvage receive systemic or intra-arterial chemotherapy coupled with focal treatments, including radiotherapy, which is associated with an increased risk for second cancers. 3, 7, [9] [10] [11] Although these complex therapies are effective, their consequences for the children and their families cannot be underestimated. 12 Finally, a small proportion of patients present with extraocular disease, which is generally associated with poor survival. 13, 14 Thus, early diagnosis and referral and prompt initiation of therapy are key to successful outcomes; ocular survival, preservation of vision, and patient survival correlate directly with the time to diagnosis. Leukocoria, the most common presentation, can be detected readily with the red reflex test on a routine examination. The American Academy of Pediatrics recommends age-appropriate assessment of eye problems, including a symmetric red reflex, at all health supervision visits from birth to 5 years of age. 15 Despite these practices that could help to detect retinoblastoma early, most US patients with retinoblastoma are still diagnosed as having overt leukocoria and a large intraocular tumor burden that requires intensive ocularsalvage treatments or enucleation. Thus, early diagnosis and successful outcomes for children with retinoblastoma are tightly related to the strength of the health care system; vulnerable, socioeconomically deprived populations are at risk for delayed diagnosis and adverse outcomes. Although disparities in access to care have been well evaluated and discussed for adult cancers, 16 little is known about pediatric cancers; in this regard, retinoblastoma may offer a unique scenario in which disparities can be analyzed. In this study we examined the relationship among ethnicity, race, and socioeconomic factors and the extent of disease at diagnosis as a surrogate marker for delayed diagnosis and access to tertiary care and the outcomes in retinoblastoma.
Methods

Selection of Study Population
The study population was selected from the Surveillance, Epidemiology, and End Results (SEER) database using the 
Socioeconomic Factors
We obtained information on each child's age at diagnosis, race, ethnicity, and state and county of residence directly from the SEER database. We also gathered area-based indicators of socioeconomic status (SES) based on the county of residence for each individual case; we chose 6 standard 2000 US Census variables, which reflected the levels of poverty, educational attainment, crowding, unemployment, immigration, and language isolation within each county. For each variable, we split the cohort into 2 groups based on the median value, which allowed for comparison of outcomes between more and less disadvantaged counties, as described in eTable 1 in the Supplement.
County Socioeconomic Deprivation Index
To analyze the joint effect of different socioeconomic factors on the outcomes of interest, we created a composite county socio-
At a Glance
• Most studies investigating disparities in childhood cancer outcomes in high-income countries have failed to show significant differences based on socioeconomic or ethnic factors.
• Hispanic children were more likely to present with extraocular disease (33.0% vs 20.0%) and were 41% more likely to undergo enucleation than non-Hispanic white children.
• Low socioeconomic status affects disease extent and ocular outcomes, presumably by limiting access to primary and cancer-directed care.
• Identifying and addressing such disparities is critical given the known morbidity and the long-term psychological, financial, and medical burden that these children and their families have to endure.
included in the index were first standardized [x -(mean/SD)] based on the values found within the patient cohort. The index was then calculated based on 2 main, equally weighted domains. The first domain reflects the joint effects of purely economic factors and is calculated by obtaining the mean standardized variables for the level of poverty (P), low educational attainment (E), crowding (C), and unemployment (U). The other domain reflects factors representing potential cultural and language barriers and is calculated based on levels of immigration (I) and language isolation (L) within the counties. The formula used to construct the index is as follows:
After the index value was calculated for each county represented in our cohort, we identified the median value. This process allowed us to compare the extent of disease and outcomes between the disadvantaged counties-those having deprivation index values that were greater than or equal to the median value-and the remaining counties.
Outcome Variables
Extent of Disease at Diagnosis A tumor was considered to be intraocular if the value of SEER database historic stage A variable was localized, whereas regional or distant values indicated extraocular tumors (eTable 2 in the Supplement). Although central pathologic review was not possible, localized, regional, and distant values were interpreted as representing a continuum of disease progression that would allow us to identify children with more advanced disease for analysis purposes. Cases without specific SEER historic stage A values were excluded from analyses on extent of disease at diagnosis.
Occurrence of Enucleation (Ocular Outcome)
We used SEER surgical codes to identify children who underwent enucleation (eTable 3 in the Supplement). We excluded cases in which we could not discern whether surgery took place or the nature of the surgical intervention (n = 8). Children with bilateral disease who might have had 2 enucleations were counted once.
Statistical Analysis
Data were analyzed from January 1, 2000, through December 31, 2010. We used the χ 2 test to verify the association between SES variables (including the individual patient's race and ethnicity, isolated SES variables, and county socioeconomic deprivation index) and the extent of disease at diagnosis and enucleation. We calculated crude odds ratios (ORs) and corresponding 95% CIs. To evaluate confounding and effect modification, analysis of the SES effect was stratified by ethnicity. We used the Mantel-Haenszel test of homogeneity to compare the ORs of different strata and to identify effect modification. 18 Given the small number of cases per registry, 
Results
Study Population
We 
Extent of Disease at Diagnosis
Among the 771 children whose extent of disease could be determined, 188 (24.4%) presented with extraocular disease as defined in the study ( Table 3) . Point estimates from stratified analysis showed that the effects of socioeconomic disadvantage on the risk of extraocular disease were higher among Hispanics for all indicators except immigration; however, homogeneity tests were not significant (Table 3) . On the other hand, none of the county socioeconomic indicators was associated with a higher risk of extraocular disease among non-Hispanic children (white non-Hispanic, black, and others) (eTable 4 in the Supplement).
Ocular Outcome
Ocular outcomes could be determined for 822 children; 574 of these children (69.8%) underwent enucleation at some point during the course of treatment. 
Survival
The 5-year relative survival rate was 97.7%. Despite differences in percentages of extraocular disease and enucleation, we found no difference in the 5-year relative survival rates between Hispanic and non-Hispanic children (97.5% vs 97.9%). However, a lower 5-year relative survival rate was observed for black compared with white non-Hispanic children (92.7% vs 99.2%; P < .001). Although we found a lower relative survival rate for the more disadvantaged counties for all SES variables studied, the difference was statistically significant only for unemployment (99.7% and 95.6% for low and high levels of unemployment, respectively; P < .001) and language isolation (99.0% and 96.3% for low and high levels of isolation, respectively; P = .04) (eTable 6 in the Supplement).
Outcomes Based on the County Socioeconomic Deprivation Index
The county socioeconomic deprivation index was calculated for each child; the mean and median values for the index were 0 and −0.17, respectively. The highest value, which indicated a high level of socioeconomic disadvantage, was 1.51 and was found in Hudson County, New Jersey; the lowest value was −1.45 in Iowa County, Iowa. Results obtained from the use of this index were consistent with the findings for individual SES variables discussed above. Children who resided in more disadvantaged counties were at higher risk for presenting with extraocular disease and undergoing enucleation than those living in more advantaged counties (Table 4) . Stratification by ethnicity (non-Hispanic and Hispanic) indicated that disparities existed within both populations; however, Hispanic children living in disadvantaged counties had a very high risk for undergoing enucleation, particularly for those with bilateral retinoblastoma (eFigure in the Supplement). Black children from more disadvantaged counties also had a higher risk for extraocular disease than their peers who resided in more advantaged counties (Table 5) . Finally, children residing in more disadvantaged counties had a lower relative survival compared with those residing in more advantaged counties (96.5% vs 98.9%), although this difference was not statistically significant (eTable 6 in the Supplement). 
Discussion
The results of our study highlight the progress made in the treatment of retinoblastoma and the disparities that have emerged as opportunities for cure and ocular salvage have become available. Retinoblastoma, once a uniformly fatal disease, is now readily curable; clinical research and innovation are focused on how to improve ocular salvage with the least short-and long-term adverse effects. 1, 3 Despite these advances, our study demonstrates a higher risk for having more advanced disease and undergoing enucleation among specific subpopulations that can be characterized by race, ethnicity, and unfavorable socioeconomic factors, such as poverty, low educational attainment, crowding, language isolation, and being part of a new immigrant community. Thus, initiatives aimed at understanding those disparities and narrowing the outcome gaps should also be prioritized. comes among black compared with white patients were noted in separate population-based 22,23 and cooperative group 24, 25 studies, but not in a single-institution study, 23 suggesting that an institution's unique ability to provide relatively uniform care could erase the gaps caused by access and treatment disparities. 21, 26 Adherence to treatment has been found to be poorer among Hispanic children with acute lymphoblastic leukemia, a fact that increases the risk for relapse. 27 Thus, treatmentrelated variables influenced by SES are the most likely factors to affect outcomes. However, many aspects of the patient's long journey from having the first symptoms to receiving the diagnosis and starting treatment are not well understood and might play an important role for diseases, such as retinoblastoma, in which timely diagnosis is crucial. Measuring survival as the sole outcome on which disparities are addressed risks overlooking the granularity of a process that may affect vulnerable populations in many other ways, particularly in retinoblastoma. 28 As shown in our study, although racial, ethnic, and socioeconomic factors do not have a significant effect on the survival of children with retinoblastoma, the extent of the disease (and thus the intensity of the treatment received) and the chances of eye salvage (and the ultimate effect on vision and quality of life) differ significantly.
The unique characteristics of the natural history of retinoblastoma, in which the disease stage clearly reflects the continuum of tumor growth until diagnosis and ocular salvage correlates directly with the intraocular disease burden, provided a unique opportunity to investigate the role of socioeconomic factors in the earlier stages along the sequence of presentation, diagnosis, and treatment. Unlike many other pediatric solid tumors, such as neuroblastoma, in which outcomes are influenced by underlying tumor-specific biological factors, no known genetic heterogeneity has been shown to correlate with outcomes in retinoblastoma. 29 However, the genomics of retinoblastoma have not been evaluated consistently across racial and ethnic groups; this situation is particularly relevant in view of the differences seen in the incidence of retinoblastoma between countries and ethnic groups. 30, 31 An inverted correlation between the incidence of retinoblastoma and socioeconomic status in heterogeneous countries, such as Brazil and Mexico, has been documented 32, 33 ; thus, some of the ethnic disparities observed are driven by the biological features of the tumor. 29 In comparison, genomic-wide interrogations have identified genetic variations as associated with susceptibility to childhood acute lymphoblastic leukemia, which could explain its increased incidence in North American Hispanic children. 34, 35 Differences in outcome by ethnic group traditionally attributed to the quality of health care may need to be redefined as genomic studies are conducted. 36 When they interrogated genome-wide germline single-nucleotide poly- genomic variation that cosegregated with Native American ancestry was associated with a risk for relapse, even after adjustment for known prognostic factors. Whether the same phenomenon is applicable to embryonal tumors, such as retinoblastoma, is not known. The high prevalence of extraocular disease among Hispanic children, particularly among those living in counties with challenging socioeconomic conditions, suggests that socioeconomic factors might have made their largest impact even before any treatment started. Hispanic children are more than twice as likely as nonHispanic white and black children to have no health care insurance. 38 Despite improvements made in disparity reduction during the past decade, access to care remains the domain with the largest proportion of disparities for Hispanic children. 39 Delivery of complex care, albeit important, might be not be as critical to prevent the loss of the eye and of vision as timely access to health supervision in the primary care setting, where early detection should occur. Given the fact that every child in the United States should undergo frequent health supervision visits, including ocular and visual examinations, 15, 40 our findings highlight the potential gaps between recommendations and the reality of access to primary care, which may be wider for the more vulnerable populations. Major efforts have been made to reduce the disparities in access to care for the pediatric socioeconomically deprived population and the ethnic and racial minorities 39 ;
however, as shown by our study, the complexity of pediatric cancer diagnosis and treatment requires dedicated analyses and interventions. Although timely access to care and the resulting effect on ocular stage is a main contributor to ocular outcome, disparities in treatment received may also exist. Treatment for ocular salvage requires sophisticated multidisciplinary care and the development of individualized treatment plans that include frequent visits for examination under anesthesia and administration of focal treatments. 12 A high adherence level is key to avoid treatment delays; vulnerable populations with limited support who face language, insurance, and financial barriers are at the greater risk for failure. As treatments for retinoblastoma become increasingly complex, disparities may worsen. Abbreviations: E, enucleated; EO, extraocular; IO, intraocular; NENU, not enucleated; OR, odds ratio. a The County Socioeconomic Deprivation Index is described in the County Socioeconomic Deprivation Index subsection of the Methods section. b Test for homogeneity of OR (Mantel-Haenszel) by ethnicity for extent of disease, P = .56; by race and ethnicity for extent of disease, P = .47. c Test for homogeneity of OR (Mantel-Haenszel) by ethnicity for ocular outcomes, P = .14; by race and ethnicity for ocular outcomes; P = .65. d Includes American Indian/Alaska Native and Asian/Pacific Islanders.
